# Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion

> **NCT01018771** · NA · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 100 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **PROCEDURE:** Actifuse ABX
- **PROCEDURE:** INFUSE, plus Mastergraft granules

## Key facts

- **NCT ID:** NCT01018771
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018771, "Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01018771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*